GNL3L and cancer: This also showed that GNL3L is negatively correlated with CD56 bright natural killer cells in the majority of cancers, especially MESO (Spearman r = −0.394, p = 0.00027), SARC (Spearman r = −0.476, p = 4.44 × 10−16), and ESCA (Spearman r = −0.380, p = 1.32 × 10−6).